In 2023, the exports of Basic Pharmaceutical Products and Pharmaceutical Preparations from China to Indonesia stood at 543.28 million USD. Over the last two years, the year-on-year variation showed an increase by 3.33% from 2022 to 2023, following a 5.89% decline from 2021 to 2022. The compounded annual growth rate (CAGR) for the past five years averaged 3.05%. From 2013 to 2023, there have been significant fluctuations but an overall upward trend is observed in exports.

Looking ahead, the forecast for 2024 to 2028 indicates a gradual increase with a five-year CAGR of 2.2%, predicting the exports will reach approximately 628.77 million USD by 2028. This projection suggests a steady growth rate of 11.47% over the five-year period.

Future trends to watch for include:

Potential impacts of regulatory changes in China or Indonesia on pharmaceutical exports.
Influence of global healthcare demands and pandemic preparedness requirements on production and export volumes.
Technological advancements in pharmaceutical manufacturing that might drive export growth.